文献速递性腺与生殖内分泌

戊酸雌二醇与炔雌醇在复方口服避孕药中的比较:对垂体-卵巢轴的影响

Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

一项随机试验的衍生研究纳入59名健康排卵女性,比较戊酸雌二醇(EV)2 mg+地诺孕素(DNG)2-3 mg、炔雌醇(EE)0.03 mg+DNG 2 mg及DNG 2 mg单用9周对生殖激素的影响;EV+DNG对FSH抑制较EE+DNG轻,SHBG升高幅度更小,游离雄激素指数降低幅度更小。

要点

  • EV+DNG使FSH降低-27%(-51%至-3%),EE+DNG降低-64%(-78至-51),P=0.04。
  • EV+DNG使SHBG升高56%(30%至82%),EE+DNG升高385%(313%至423%),P<0.001。
  • DNG单用未引起上述任何参数的变化。

核心结论

  • 与EE+DNG相比,EV+DNG治疗导致更轻微的垂体下调及更弱的肝脏SHBG合成诱导,可能带来更多有益健康效应。

研究设计与样本

  • 一项随机试验的衍生研究,纳入59名18至35岁健康排卵女性门诊患者,随机分为EV 2 mg+DNG 2-3 mg组(n=20)、EE 0.03 mg+DNG 2 mg组(n=20)和DNG 2 mg组(n=19),治疗9周,于基线、第5周和第9周采血。

主要发现

  • EV+DNG使FSH降低-27%(-51%至-3%),EE+DNG降低-64%(-78至-51),P=0.04。
  • EV+DNG使AMH降低-9%(-18至-0.1),EE+DNG降低-13%(-28至0.2),P=0.38。
  • EV+DNG使SHBG升高56%(30%至82%),EE+DNG升高385%(313%至423%),P<0.001。
  • EV+DNG组总睾酮降低16%(-27%至-5%),EE+DNG组未降低;游离雄激素指数EV+DNG组降低-39%(-54%至-25%),EE+DNG组降低-72%(-78%至-67%),P<0.001。
  • DNG单用未引起上述任何参数的变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Limited studies have compared the effects of combined oral contraceptives (COCs) containing natural estrogens and synthetic ethinylestradiol (EE) on reproductive hormones. OBJECTIVE: To compare estradiol valerate (EV) + dienogest (DNG), EE + DNG, and DNG alone (active control) on levels of follicle stimulating hormone (FSH), luteinizing hormone, anti-Müllerian hormone (AMH), ovarian steroids, sex hormone binding globulin (SHBG), and the free androgen index (FAI). METHODS: This spin-off study from a randomized trial enrolled 59 healthy, 18 to 35-year-old ovulatory women, outpatients at Helsinki and Oulu University Hospitals, Finland, who were randomized to EV 2 mg + DNG 2-3 mg (n = 20); EE 0.03 mg + DNG 2 mg (n = 20); and DNG 2 mg (n = 19) for 9 weeks. Blood samples were drawn at baseline, and at 5 and 9 weeks. Age and BMI were comparable between groups; 3 women discontinued. RESULTS: EV + DNG suppressed FSH by -27% (-51% to -3%) (median [95% CI]) vs EE + DNG, -64% (-78 to -51), P = 0.04, but AMH levels decreased similarly by -9% (-18 to -0.1) vs -13% (-28 to 0.2), P = 0.38, respectively. EV + DNG increased SHBG levels by 56% (30% to 82%) and EE + DNG by 385% (313% to 423%), P < 0.001. Total testosterone decreased by 16% (-27% to -5%) in the EV + DNG group but it did not decrease in the EE + DNG group, whereas the FAI decreased by -39% (-54% to -25%) vs -72% (-78% to -67%), P < 0.001. DNG alone did not induce changes in any of these parameters. CONCLUSION: Compared with EE + DNG, treatment with EV + DNG resulted in milder pituitary downregulation and reduced induction of hepatic SHBG synthesis-potentially carrying more beneficial health effects.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Haverinen A, Luiro K, Kangasniemi MH, et al. Estradiol Valerate vs Ethinylestradiol in Combined Oral Contraceptives: Effects on the Pituitary-Ovarian Axis. J Clin Endocrinol Metab. 2022. PMID: 35279718. doi:10.1210/clinem/dgac150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。